2015

Quality Performance Results Table

Measure
Number
ACO-1
ACO-2
ACO-3
ACO-4
ACO-5
ACO-6
ACO-7
ACO-34
ACO-8

2015 reporting period

Mean Performance
ACO Performance Rate
Rate (SSP- ACOs)
85.50
80.61
93.97
92.65
92.93
91.94
85.28
83.61
66.73
59.06
76.96
75.17
75.00
72.30
23.07
26.87
15.16
14.86

Measure Name
CAHPS: Getting Timely Care, Appointments, and Information
CAHPS: How Well Your Providers Communicate
CAHPS: Patients' Rating of Provider
CAHPS: Access to Specialists
CAHPS: Health Promotion and Education
CAHPS: Shared Decision Making
CAHPS: Health Status/ Functional Status
CAHPS: Stewardship of Patient Resources*
Risk Standardized, All Condition Readmission
Skilled Nursing Facility 30- Day All-Cause Readmission Measure (SNFRM)*
ACO-35
Readmission
18.37
ACO-36
All-Cause Unplanned Admission for Patients with Diabetes*
54.83
ACO-37
All-Cause Unplanned Admissions for Patients with Heart Failure*
77.78
ACO-38
All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions
63.21
Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary
Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #
ACO-9
5)
1.24
Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention
ACO-10
Quality Indicator (PQI) # 8)
1.00
Percent of Primary Care Physicians who Sucessfully Meet Meaningful Use
ACO-11
Requirements
90.67
ACO-39
Documentation of Current Medications in the Medical Record*
89.16
ACO-13
Falls: Screening for Future Fall Risk
75.18
ACO-14
Preventative Care and Screening: Influenza Immunization
67.25
ACO-15
Pneumonia Vaccination Status for Older Adults
63.96
Preventative Care and Screening: Body Mass Index (BMI) Screening and Follow-
ACO-16
Up
74.04
Preventative Care and Screening: Tobacco Use: Screening and Cessation
ACO-17
Intervention
92.40
Preventative Care and Screening: Screening for Clinical Depression and Follow-
ACO-18
Up Plan
66.49
ACO-19
Colorectal Cancer Screening
67.13
ACO-20
Breast Cancer Screening
76.08
Preventative Care and Screening: Screening for High Blood Pressure and Follow-
ACO-21
Up Documented
93.77
ACO-40
Depression Remission at Twelve Months*
N/A
ACO-27
Diabetes Mellitus: Hemoglobin A1c Poor Control
11.76
ACO-41
Diabetes: Eye Exam*
44.71
ACO-28
Hypertension: Controlling High Blood Pressure
76.91
ACO-30
Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic
92.25
Heart Failure: Beta- Blocker Therapy for Left Ventricular Systolic Dysfunction
ACO-31
(LVSD)
80.21
Angiotensin- Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor
Blocker (ARB) Therapy- for patients with CAD and Diabetes or Left Ventricular
ACO-33
Systolic Dysfunction (LVEF < 40%)
87.04
CAHPS= Consumer Assessment of Healthcare Providers and Systems, PQI= Prevention Quality Indicator, LVSD= left ventricular systolic
dysfunction, ACE= angiotensin- converting enzyme, ARB= angiotensin receptor blocker, CAD= coronary artery disease.
*=Measure required beginning Reporting Year 2015.
N/A= Reporting on the depression remission measure is not required for 2015, as indicated by N/A

18.07
54.60
76.96
62.92

1.11
1.04
80.14
84.07
56.46
62.03
63.73
71.15
90.16
42.25
60.06
65.67
70.04
N/A
20.38
41.05
69.62
83.82
87.22

77.73